Researchers have identified a panel of five plasma proteins that can predict the development of metabolic dysfunction-associated steatotic liver disease up to 16 years before symptoms appear, offering the potential for early intervention and improved accuracy rates when combined with clinical parameters. This discovery could lead to the development of effective biomarkers and predictive models for early prediction and intervention of the most prevalent form of liver disease worldwide.

Source: DDW